Blue Trust Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Blue Trust Inc's PFE Position: Q2 2026 in Review
Blue Trust Inc reduced its Pfizer (PFE) stake by 3.9% in Q2 2026, selling an estimated $117K and leaving 110,872 shares worth $2.67M. The position accounts for 0.03% of the portfolio, ranked #164.
Blue Trust Inc first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.32M in Q4 2024. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Blue Trust Inc held 110,872 shares of Pfizer worth $2.67M as of Q2 2026.
- Blue Trust Inc sold 4,484 Pfizer shares in Q2 2026, an estimated $117K.
- Pfizer made up 0.03% of Blue Trust Inc's portfolio in Q2 2026, its #164 holding.
- Blue Trust Inc first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
- Blue Trust Inc's Pfizer position peaked at $3.32M in Q4 2024.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.